Bisaramil
Alternative Names: RGH 2957; YutacLatest Information Update: 24 Oct 2021
At a glance
- Originator Gedeon Richter
- Developer Taiho Pharmaceutical
- Class Benzoic acids; Class Ic antiarrhythmics; Class IV antiarrhythmics; Small molecules
- Mechanism of Action Calcium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias